An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Flaxman Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Yonker, 2020, Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection, Pediatr Pulmonol, 55, 1085, 10.1002/ppul.24748 Dong, 2020, Epidemiology of COVID-19 among children in China, Pediatrics, 10.1542/peds.2020-0702 Nicastro, 2020, A pediatric emergency department protocol to avoid intra-hospital dispersal of SARS-CoV-2 during the outbreak in Bergamo, Italy, J Pediatr, 10.1016/j.jpeds.2020.04.026 Xiao, 2020, Evidence for gastrointestinal infection of SARS-CoV-2, Gastroenterology, 158, 1831, 10.1053/j.gastro.2020.02.055 Henderson, 2020, On the alert for cytokine storm: immunopathology in COVID-19, Arthritis Rheumatol, 10.1002/art.41285 D'Antiga, 2020, Coronaviruses and immunosuppressed patients. The facts during the third epidemic, Liver Transpl, 10.1002/lt.25756 Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, 395, 1033, 10.1016/S0140-6736(20)30628-0 Kawasaki, 1974, A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan, Pediatrics, 54, 271, 10.1542/peds.54.3.271 Kato, 1996, Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients, Circulation, 94, 1379, 10.1161/01.CIR.94.6.1379 Kanegaye, 2009, Recognition of a Kawasaki disease shock syndrome, Pediatrics, 123, e783, 10.1542/peds.2008-1871 Wang, 2015, Macrophage activation syndrome in Kawasaki disease: more common than we thought?, Semin Arthritis Rheum, 44, 405, 10.1016/j.semarthrit.2014.07.007 Rowley, 2018, Is Kawasaki disease an infectious disorder?, Int J Rheum Dis, 21, 20, 10.1111/1756-185X.13213 McCrindle, 2017, Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association, Circulation, 135, e927, 10.1161/CIR.0000000000000484 Ravelli, 2016, Ann Rheum Dis, 75, 481, 10.1136/annrheumdis-2015-208982 García-Pavón, 2017, Kawasaki disease complicated with macrophage activation syndrome: a systematic review, J Pediatr Hematol Oncol, 39, 445, 10.1097/MPH.0000000000000872 Kobayashi, 2012, Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial, Lancet, 379, 1613, 10.1016/S0140-6736(11)61930-2 Shulman, 2015, Kawasaki disease: insights into pathogenesis and approaches to treatment, Nat Rev Rheumatol, 11, 475, 10.1038/nrrheum.2015.54 Nakamura, 2018, Kawasaki disease: epidemiology and the lessons from it, Int J Rheum Dis, 21, 16, 10.1111/1756-185X.13211 Nakamura, 2012, Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey, J Epidemiol, 22, 216, 10.2188/jea.JE20110126 Yim, 2013, Update on Kawasaki disease: epidemiology, aetiology and pathogenesis, J Paediatr Child Health, 49, 704, 10.1111/jpc.12172 Makino, 2015, Descriptive epidemiology of Kawasaki disease in Japan, 2011–2012: from the results of the 22nd nationwide survey, J Epidemiol, 25, 239, 10.2188/jea.JE20140089 Onouchi, 2018, The genetics of Kawasaki disease, Int J Rheum Dis, 21, 26, 10.1111/1756-185X.13218 Holman, 2010, Hospitalizations for Kawasaki syndrome among children in the United States, 1997–2007, Pediatr Infect Dis J, 29, 483, 10.1097/INF.0b013e3181cf8705 Marchesi, 2018, Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase, Ital J Pediatr, 44, 102, 10.1186/s13052-018-0536-3 Esper, 2005, Association between a novel human coronavirus and Kawasaki disease, J Infect Dis, 191, 499, 10.1086/428291 McIntosh, 2005, Coronaviruses in the limelight, J Infect Dis, 191, 489, 10.1086/428510 Ebihara, 2005, Lack of association between New Haven coronavirus and Kawasaki disease, J Infect Dis, 192, 351, 10.1086/430797 Esper, 2005, Reply to van der Hoek and Berkhout, Ebihara et al., and Belay et al, J Infect Dis, 192, 353, 10.1086/430796 Turnier, 2015, Concurrent respiratory viruses and Kawasaki disease, Pediatrics, 136, e609, 10.1542/peds.2015-0950 Shirato, 2014, Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease, J Med Virol, 86, 2146, 10.1002/jmv.23950 McGonagle, 2020, The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease, Autoimmun Rev, 10.1016/j.autrev.2020.102537 Molloy, 2020, COVID-19 in children and altered inflammatory responses, Pediatr Res, 10.1038/s41390-020-0881-y Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3